Posted in Web Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in … February 1, 2025 Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain https://investors.vrtx.com/news-releases/news-release-details/vertex-announces-fda-approval-journavxtm-suzetrigine-first-class